help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 4, No. 1 80-90
doi:10.1210/mend-4-1-80
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Ascoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Ascoli, M.

Reduced Gonadotropin Responses in a Novel Clonal Strain of Leydig Tumor Cells Established by Transfection of MA-10 Cells with a Mutant Gene of the Type I Regulatory Subunit of the cAMPDependent Protein Kinase

Haiyun Wang* and Mario Ascoli

The Population Council New York, New York 10021

Address requests for reprints to: Dr. Mario Ascoli, The Population Council, 1230 York Avenue, New York, New York 10021.

Abstract

Although it is clear that cAMP is an important mediator of the actions of LH/CG in Leydig cells, recent studies from several laboratories have shown that the functions of Leydig cells can also be modulated by hormones and growth factors that do not appear to use cAMP as a second messenger. Thus, in order to increase our understanding of the importance of cAMP as a modulator of the functions of Leydig cells we have used a genetic approach to establish permanent cell lines that express a cAMP-resistant phenotype.

MA-10 cells, a clonal strain of cultured Leydig tumor cells that express many of the characteristics of normal Leydig cells, were transfected with an expression vector controlled by the metallothionein promoter and encoding for a mutant form of the regulatory subunit of the type I cAMP-dependent protein kinase. Three stable transfectants that display a Zn+2-dependent decrease in cAMP-dependent protein kinase activity were established. Further characterization of one of the transfectants (designated MA-10(K3)) revealed a parallel reduction in the ability of cAMP and human CG to induce cell rounding, to increase steroid synthesis, or to induce c-fos mRNA.

Our initial studies on these mutant cells have already provided novel information about the actions of human CG. These cell lines will also be valuable for further studies on the signaling systems that mediate hormone action in Leydig cells.

FOOTNOTES

This work was supported by NIH Grant CA-40629. Cyclic AMP Resistant Mutants of MA-10 Cells

* Supported by a fellowship from the Andrew W. Mellon Foundation.

Received for publication September 21, 1989. Revision received October 17, 1989. Accepted for publication October 17, 1989.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R S Bhaskaran and M Ascoli
The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses
J. Mol. Endocrinol., April 1, 2005; 34(2): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Chu, C. J. Corbin, M. A. Kaminski, and A. J. Conley
Unique Regulation of CYP17 Expression in the Trophectoderm of the Preattachment Porcine Blastocyst
Endocrinology, February 1, 1999; 140(2): 632 - 640.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society